Clinical Trial Update: JS-201 Combined With Lenvatinib in the Treatment of Small-cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update showing JS-201 in combination with lenvatinib for small-cell lung cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• JS-201
• Lenvatinib (lenvatinib)

Snippet

Sponsor: Hunan Province Tumor Hospital | Conditions: Small-cell Lung Cancer | Phase 2 | Status: RECRUITING